• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

列线图预测Ⅰ期老年小细胞肺癌患者生存的建立与验证。

Development and validation of nomograms for predicting survival of elderly patients with stage I small-cell lung cancer.

机构信息

Department of Anesthesia, Chongqing Medical University, Chongqing, China.

Department of Pharmacy Practice, College of Pharmacy and Health Sciences, Western New England University, Springfield, United States; Department of Pharmacy, Xiangya Hospital Central South University, Changsha, Hunan, China.

出版信息

Bosn J Basic Med Sci. 2021 Oct 1;21(5):632-641. doi: 10.17305/bjbms.2020.5420.

DOI:10.17305/bjbms.2020.5420
PMID:33577444
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8381200/
Abstract

There is a lack of predictive models to determine the prognosis of elderly patients diagnosed with Stage I small-cell lung cancer (SCLC). The purpose of this study was to establish a useful nomogram to predict cancer-specific survival (CSS) in the elderly patient population. Based on the Surveillance, Epidemiology, and End Results registry database, patients aged ≥ 65 years with pathological AJCC (American Joint Committee on Cancer) Stage I SCLC from 2004 to 2014 were identified. The CSS was evaluated by the Kaplan-Meier method. Patients were randomly split into training and validation sets. In the training cohort, univariate analysis and multivariate analysis using the Cox regression identified risk factors that affected CSS, and the results were utilized to construct a nomogram for prediction of the 1-, 3-, and 5-year CSS rates of elderly patients with Stage I SCLC. The effectiveness of the nomogram was validated internally and externally by the bootstrap method. The clinical practicability and accuracy of the nomogram were evaluated by the concordance index (C-index), calibration curve, receiver operating characteristic curve, and decision curve analysis. In total, we extracted 1,623 elderly patients with Stage I SCLC. The median CSS was 34 months, and the 5-year CSS was 41%. Multivariate analysis revealed that histologic type, tumor size, age, and AJCC Stage were significant predictors of CSS. A nomogram was constructed according to the results of multivariate COX analysis. The C-indices of the nomogram for training and validation sets were 0.68 and 0.62, indicating that the nomogram demonstrated a favorable level of discrimination. The calibration curves exhibited satisfactory agreement between the actual observation and nomogram prediction. The net benefit of the nomogram was better than the AJCC TNM staging. A practical nomogram to predict the CSS of elderly patients with Stage I SCLC is constructed. The predictive tool is helpful for patient counseling and treatment decision-making.

摘要

对于诊断为 I 期小细胞肺癌(SCLC)的老年患者,目前缺乏预测预后的模型。本研究旨在建立一个有用的列线图,以预测老年患者人群的癌症特异性生存(CSS)。基于监测、流行病学和最终结果(SEER)登记数据库,确定了 2004 年至 2014 年间年龄≥65 岁、具有病理 AJCC(美国癌症联合委员会)I 期 SCLC 的患者。通过 Kaplan-Meier 方法评估 CSS。患者被随机分为训练集和验证集。在训练队列中,使用 Cox 回归进行单因素和多因素分析,确定影响 CSS 的危险因素,并利用这些结果构建预测 I 期 SCLC 老年患者 1、3 和 5 年 CSS 率的列线图。通过自举法对内外部验证了该列线图的有效性。通过一致性指数(C-index)、校准曲线、接收者操作特征曲线和决策曲线分析评估了列线图的临床实用性和准确性。总共提取了 1623 例 I 期 SCLC 老年患者。中位 CSS 为 34 个月,5 年 CSS 为 41%。多因素分析显示组织学类型、肿瘤大小、年龄和 AJCC 分期是 CSS 的显著预测因素。根据多因素 COX 分析的结果构建了一个列线图。训练集和验证集的列线图 C-index 分别为 0.68 和 0.62,表明列线图具有良好的区分度。校准曲线显示实际观察值与列线图预测值之间具有良好的一致性。列线图的净效益优于 AJCC TNM 分期。构建了一个预测 I 期 SCLC 老年患者 CSS 的实用列线图。该预测工具有助于为患者提供咨询和治疗决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e36b/8381200/1dd518731de5/BJBMS-24-632-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e36b/8381200/e8fe71ce4a9d/BJBMS-24-632-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e36b/8381200/a7db5d27b7c2/BJBMS-24-632-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e36b/8381200/6becad3cfb09/BJBMS-24-632-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e36b/8381200/52c6971562dc/BJBMS-24-632-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e36b/8381200/1dd518731de5/BJBMS-24-632-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e36b/8381200/e8fe71ce4a9d/BJBMS-24-632-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e36b/8381200/a7db5d27b7c2/BJBMS-24-632-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e36b/8381200/6becad3cfb09/BJBMS-24-632-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e36b/8381200/52c6971562dc/BJBMS-24-632-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e36b/8381200/1dd518731de5/BJBMS-24-632-g008.jpg

相似文献

1
Development and validation of nomograms for predicting survival of elderly patients with stage I small-cell lung cancer.列线图预测Ⅰ期老年小细胞肺癌患者生存的建立与验证。
Bosn J Basic Med Sci. 2021 Oct 1;21(5):632-641. doi: 10.17305/bjbms.2020.5420.
2
A new nomogram and risk classification system for predicting survival in small cell lung cancer patients diagnosed with brain metastasis: a large population-based study.一个用于预测小细胞肺癌脑转移患者生存的新列线图和风险分类系统:一项大型基于人群的研究。
BMC Cancer. 2021 May 29;21(1):640. doi: 10.1186/s12885-021-08384-5.
3
Prognostic Nomogram for Overall Survival in Small Cell Lung Cancer Patients Treated with Chemotherapy: A SEER-Based Retrospective Cohort Study.化疗治疗小细胞肺癌患者总生存预后列线图:基于 SEER 的回顾性队列研究。
Adv Ther. 2022 Jan;39(1):346-359. doi: 10.1007/s12325-021-01974-6. Epub 2021 Nov 3.
4
Development and validation of a nomogram for predicting cancer-specific survival in small-bowel adenocarcinoma patients using the SEER database.基于 SEER 数据库的列线图模型构建与验证:用于预测小肠腺癌患者癌症特异性生存的研究。
World J Surg Oncol. 2024 Jun 7;22(1):151. doi: 10.1186/s12957-024-03438-x.
5
Comparation between novel online models and the AJCC 8th TNM staging system in predicting cancer-specific and overall survival of small cell lung cancer.新型在线模型与 AJCC 第 8 版 TNM 分期系统预测小细胞肺癌患者癌症特异性和总生存期的比较。
Front Endocrinol (Lausanne). 2023 Jul 25;14:1132915. doi: 10.3389/fendo.2023.1132915. eCollection 2023.
6
The nomograms for predicting overall and cancer-specific survival in elderly patients with early-stage lung cancer: A population-based study using SEER database.基于 SEER 数据库的人群研究:用于预测老年早期肺癌患者总生存和癌症特异生存的列线图。
Front Public Health. 2022 Sep 8;10:946299. doi: 10.3389/fpubh.2022.946299. eCollection 2022.
7
Construction and Validation of a Novel Nomogram to Predict the Overall Survival of Patients With Combined Small Cell Lung Cancer: A Surveillance, Epidemiology, and End Results Population-Based Study.构建和验证一种新型列线图预测小细胞肺癌合并患者总生存期的方法:一项监测、流行病学和最终结果的基于人群的研究。
Cancer Control. 2021 Jan-Dec;28:10732748211051228. doi: 10.1177/10732748211051228.
8
Nomogram predicting cancer-specific survival in elderly patients with stages I-III colon cancer.预测 I-III 期老年结肠癌患者癌症特异性生存的列线图。
Scand J Gastroenterol. 2020 Feb;55(2):202-208. doi: 10.1080/00365521.2020.1720280. Epub 2020 Feb 1.
9
Prognostic Factors and a Nomogram Predicting Overall Survival and Cancer-Specific Survival for Patients with Collecting Duct Renal Cell Carcinoma.预测肾集合管细胞癌患者总生存和癌症特异性生存的预后因素和列线图。
Biomed Res Int. 2021 Nov 11;2021:6736008. doi: 10.1155/2021/6736008. eCollection 2021.
10
Development and validation of a nomogram to predict the prognosis of patients with gastric cardia cancer.开发和验证一个列线图模型以预测胃贲门癌患者的预后。
Sci Rep. 2020 Aug 24;10(1):14143. doi: 10.1038/s41598-020-71146-z.

引用本文的文献

1
Development and validation of a CT-based radiomics nomogram for predicting progression-free survival in patients with small cell lung cancer.基于CT的影像组学列线图在预测小细胞肺癌患者无进展生存期方面的开发与验证
BMC Med Imaging. 2025 May 6;25(1):154. doi: 10.1186/s12880-025-01691-4.
2
A practical nomogram for predicting early death in elderly small cell lung cancer patients: A SEER-based study.用于预测老年小细胞肺癌患者早期死亡的实用列线图:基于 SEER 的研究。
Medicine (Baltimore). 2024 Apr 26;103(17):e37759. doi: 10.1097/MD.0000000000037759.
3
Construction and validation of a nomogram to predict the overall survival of small cell lung cancer: a multicenter retrospective study in Shandong province, China.

本文引用的文献

1
Trends of incidence and prognosis of upper tract urothelial carcinoma.上尿路尿路上皮癌的发病趋势和预后。
Bosn J Basic Med Sci. 2021 Oct 1;21(5):607-619. doi: 10.17305/bjbms.2020.5345.
2
The Ki-67 proliferation index predicts recurrence-free survival in patients with dermatofibrosarcoma protuberans.Ki-67 增殖指数可预测隆突性皮肤纤维肉瘤患者的无复发生存。
Bosn J Basic Med Sci. 2021 Apr 1;21(2):174-178. doi: 10.17305/bjbms.2020.5088.
3
Nomogram model for predicting cause-specific mortality in patients with stage I small-cell lung cancer: a competing risk analysis.
构建并验证用于预测小细胞肺癌总生存期的列线图:一项来自中国山东省的多中心回顾性研究。
BMC Cancer. 2023 Dec 1;23(1):1182. doi: 10.1186/s12885-023-11692-7.
4
A prognostic nomogram to predict survival in elderly patients with small-cell lung cancer: a large population-based cohort study and external validation.一个用于预测老年小细胞肺癌患者生存的预后列线图:一项大型基于人群的队列研究和外部验证。
BMC Cancer. 2022 Dec 6;22(1):1271. doi: 10.1186/s12885-022-10333-9.
5
Additional Postoperative Radiotherapy Prolonged the Survival of Patients with I-IIA Small Cell Lung Cancer: Analysis of the SEER Database.术后追加放疗可延长I-IIA期小细胞肺癌患者的生存期:美国监测、流行病学和最终结果(SEER)数据库分析
J Oncol. 2022 Jun 18;2022:6280538. doi: 10.1155/2022/6280538. eCollection 2022.
列线图模型预测 I 期小细胞肺癌患者的特定原因死亡率:竞争风险分析。
BMC Cancer. 2020 Aug 24;20(1):793. doi: 10.1186/s12885-020-07271-9.
4
Construction of a nomogram predicting the overall survival of patients with distantly metastatic non-small-cell lung cancer.预测远处转移性非小细胞肺癌患者总生存期的列线图构建
Cancer Manag Res. 2018 Nov 22;10:6143-6156. doi: 10.2147/CMAR.S183878. eCollection 2018.
5
Prognostic Analysis of Limited Resection Versus Lobectomy in Stage IA Small Cell Lung Cancer Patients Based on the Surveillance, Epidemiology, and End Results Registry Database.基于监测、流行病学和最终结果登记数据库对ⅠA期小细胞肺癌患者行有限切除与肺叶切除术的预后分析
Front Genet. 2018 Nov 22;9:568. doi: 10.3389/fgene.2018.00568. eCollection 2018.
6
A pooled analysis of individual patient data from National Clinical Trials Network clinical trials of concurrent chemoradiotherapy for limited-stage small cell lung cancer in elderly patients versus younger patients.一项汇集了 National Clinical Trials Network 临床试验中关于局限期小细胞肺癌老年患者与年轻患者同期放化疗的个体患者数据的汇总分析。
Cancer. 2019 Feb 1;125(3):382-390. doi: 10.1002/cncr.31813. Epub 2018 Oct 21.
7
Analysis of unexpected small cell lung cancer following surgery as the primary treatment.分析作为主要治疗方法的手术治疗后意外出现的小细胞肺癌。
J Cancer Res Clin Oncol. 2018 Dec;144(12):2441-2447. doi: 10.1007/s00432-018-2766-6. Epub 2018 Oct 20.
8
Tumor size and lymph node metastasis are prognostic markers of small cell lung cancer in a Chinese population.肿瘤大小和淋巴结转移是中国人群中小细胞肺癌的预后标志物。
Medicine (Baltimore). 2018 Aug;97(31):e11712. doi: 10.1097/MD.0000000000011712.
9
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 5.2018.NCCN 指南解读:非小细胞肺癌,第 5 版,2018 年。
J Natl Compr Canc Netw. 2018 Jul;16(7):807-821. doi: 10.6004/jnccn.2018.0062.
10
Evaluation of short-term and long-term efficacy of surgical and non-surgical treatment in patients with early-stage small cell lung cancer: A comparative study.早期小细胞肺癌患者手术与非手术治疗的短期和长期疗效评估:一项对比研究。
Cancer Biomark. 2017 Jul 4;19(3):249-256. doi: 10.3233/CBM-160332.